The first personalized vaccine for a type of cancer was tested on an English patient.
The world’s first skin cancer vaccine, tested on patients by the UK’s National Health Service, is described by experts as one of the most exciting advances in modern cancer treatment, produced with great technical finesse.
This vaccine targets individuals with high-risk melanomas and is the world’s first personalized vaccine for skin cancer.
It is tailored for each individual, aiming to identify cancer cells and prevent disease recurrence. A tumor sample is taken, its sequence is determined, and artificial intelligence also plays a role, making it arguably smarter than traditional vaccines.
This is the final stage of testing for this vaccine. In the second phase of testing, there is a significant reduction in the risk of cancer recurrence.
Persian
مشاهده این مقاله به زبان فارسی
